(NYSE: DGX) Quest Diagnostics's forecast annual revenue growth rate of 6.65% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.79%.
Quest Diagnostics's revenue in 2025 is $9,539,000,000.On average, 8 Wall Street analysts forecast DGX's revenue for 2025 to be $1,202,873,010,721, with the lowest DGX revenue forecast at $1,194,394,051,881, and the highest DGX revenue forecast at $1,209,841,592,931. On average, 9 Wall Street analysts forecast DGX's revenue for 2026 to be $1,243,065,972,244, with the lowest DGX revenue forecast at $1,205,755,361,155, and the highest DGX revenue forecast at $1,260,805,084,576.
In 2027, DGX is forecast to generate $1,294,356,049,909 in revenue, with the lowest revenue forecast at $1,291,945,720,075 and the highest revenue forecast at $1,297,626,932,788.